This guideline provides evidence-based recommendations for nice 2024 - ovarian cancer identifying and managing familial and genetic risk. It is intended for use by healthcare professionals in clinical practice. Key recommendations f or resear ch .................................................................................................... 37 Other r ecommendations f or resear ch ................................................................................................. 39 Rationale and impact ................................................................................................................... 40 Organisation of ser vices ...........................................................